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Abstract
Objective. To investigate in the general population the clinical impact of erosive OA in interphalangeal
joints (IPJs) compared with symptomatic radiographic hand OA and inflammatory arthritis.
Methods. Standardized assessments with hand radiographs were performed in participants of two popu-
lation-based cohorts in North Staffordshire with hand symptoms lasting 51 day in the past month. Erosive
OA was defined as the presence of an eroded or remodelled phase in 51 IPJ using the VerbruggenVeys
method. Radiographic hand OA was defined as the presence of 51 IPJ/first carpometacarpal joint with a
KellgrenLawrence score of 52. Diagnoses of inflammatory arthritis were based on medical records.
Hand pain and disability were assessed with the Australian/Canadian Hand Osteoarthritis Index
(AUSCAN). Linear regression analyses were used to compare clinical determinants between groups and
calculate mean differences with 95% CIs, adjusted for age and sex.
Results. Of 1076 participants with hand symptoms [60% women, mean age 64.8 years (S.D. 8.3 years)]; 80
persons (7.4%) had erosive OA. The population prevalence of erosive OA in 51 IPJ was 2.4% (95% CI
1.8, 3.0). Persons with erosive OA reported more pain and disability than persons with symptomatic
radiographic hand OA [adjusted mean difference 1.3 (95% CI 0.3, 2.3) and 2.3 (95% CI 0.4, 4.2), respect-
ively]. Individuals with inflammatory arthritis (n= 44) reported more pain and disability than those with
erosive OA [adjusted mean difference 1.7 (95% CI 0.05, 3.4) and 6.3 (95% CI 2.8, 9.9), respectively].
Conclusion. While erosive OA has a greater impact than symptomatic radiographic hand OA in the
general population, it is not as severe in terms of hand pain and disability as inflammatory RA.
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Introduction
Erosive OA of the hand is thought to be a subset of hand
OA [1] and was first described by Peter et al. in 1966 [2].
The clinical features in erosive OA can appear as pain,
swelling, redness, warmth and limited function of the
interphalangeal joints (IPJs), which can be absent in
non-erosive OA [3]. However, it is only recently that re-
search into the occurrence of erosive OA in large-scale
epidemiological studies has become possible with the de-
velopment and validation of standardized methods for
scoring cardinal features of IPJs, central erosions and col-
lapse of the subchondral bone plate on radiographs [46].
The Rotterdam cohort was one of the first studies to
provide a population prevalence of erosive OA in the
IPJs of 2.8% of adults age555 years in the general popu-
lation, equivalent to 1 in 10 people with symptomatic hand
OA [7]. Shortly after this, the Framingham Study showed
age-standardized prevalence estimates for erosive OA of
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9.9% in women and 3.3% in men [8]. These, and other
previous studies in clinical populations, have consistently
found more severe symptoms and functional limitations
among those with erosive OA than those with non-erosive
OA [710], raising the concern that erosive OA may carry
the same burden as seen in inflammatory arthritis. This
concern was mainly raised by studies performed in
rheumatology practices in secondary and tertiary care
comparing patients with hand OA with patients with RA
[11, 12]. In rheumatology practices, the proportion of pa-
tients with erosive OA is relatively high. In these studies
the clinical burden was similar between patients with hand
OA and RA. However, a study comparing patient groups
referred to a rheumatology outpatient clinic may lead to
selection bias, since the high clinical burden in itself can
be a reason for referral.
The aims of this study were to confirm the prevalence of
erosive OA in a general population sample in the UK, to
explore the impact of erosive OA on clinical outcomes
further and to investigate the clinical impact of erosive
OA compared with inflammatory arthritis arising from a
population-based UK cohort with hand symptoms.
Methods
Population and study design
Data were collected from the Clinical Assessment Study
of the Hand (CAS-HA) and Knee (CAS-K), both prospect-
ive, population-based, observational cohort studies in
North Staffordshire, UK. The protocols of these studies
are described elsewhere in detail [13, 14]. In short, all
adults age 550 years registered with two general prac-
tices were invited to participate in a two-stage postal
survey. If they indicated that they had experienced hand
pain or hand problems within 412 months on the first
postal questionnaire they were invited to the research
clinic. Those who attended the research clinic were
included in the CAS-HA study (n= 623) [13]. CAS-K par-
ticipants (n= 819) were recruited from a further three dif-
ferent general practices using recruitment methods
identical to CAS-HA, except that participants were invited
for a clinical assessment in the CAS-K study if they re-
ported knee pain (rather than hand pain or hand problems)
within the last year [14]. Ethical approval for the CAS-HA
and CAS-K studies was obtained from the North
Staffordshire Local Research Ethics Committee and all
participants gave written consent for those studies. No
patient consent or ethical approval was obtained for this
study, as the data are based on CAS-K and CAS-HA stu-
dies. Only CAS-HA or CAS-K participants who indicated
that they experienced hand symptoms (pain, aching, stiff-
ness) 51 day during the past month are included in this
article. This criterion was selected in order enable com-
parison of prevalences with the Rotterdam Study [7],
where patients with hand pain during the past month
were selected (instead of using the selection of pain
during the past year).
OA definitions
Radiographic hand OA was defined as a Kellgren-
Lawrence (KL) score of 52 in at least one IPJ or the
first carpometacarpal joint (CMCJ). Symptomatic radio-
graphic hand OA was defined as having hand symptoms
(pain, aching or stiffness 51 day during last month) and
radiographic OA. Erosive OA is defined as having one or
more E or R phase according to VerbruggenVeys in the
distal IPJ (DIPJ), proximal IPJ (PIPJ) or first IPJ.
Radiographic assessment and scoring
Plain radiographs were completed of each hand in a pos-
teroanterior (PA) view [13]. Distal, proximal and thumb IPJ
(DIP, PIP and first IPJ) and first CMCJ were scored by two
trained assessors (M.M. scored, n= 521; June Hand
scored, n= 555) blinded for clinical data. Joints were
scored for the presence and severity of OA with the KL
score (range 04) [15]. Both observers re-scored 50 pairs
to calculate inter- and intra-observer reliability. Inter-ob-
server reliability for the presence of hand OA was moder-
ate (k= 0.5, percentage agreement 90%). The intra-
observer reliability for the presence of hand OA was ex-
cellent (k= 0.92 and 0.85, PA 98% and 98% for readers 1
and 2, respectively).
Erosions were scored by the VerbruggenVeys scoring
method [5] and defined as having eroded (E phase) or re-
modelled, irregular, sclerotic subchondral plates (R phase)
in DIPJs, PIPJs and first IPJs. The VerbruggenVeys scor-
ing does not include first IPJs; however, the same rules for
DIPJs and PIPJs were applied to this joint, again permit-
ting direct comparison with the Rotterdam Study [7].
Erosions were scored by a single reader (W.K.), blinded
for clinical data. The intra-observer reliability for erosions
as a dichotomous variable in the VerbruggenVeys scor-
ing method was excellent (k= 0.94) [16].
Sample selection for scoring erosive disease in hand
radiographs
The majority of hand radiographs were scored for ero-
sions; exceptions were those radiographs that had no or
very few OA features. The assumption was that erosions
are not present in subjects with (almost) normal radio-
graphs. To determine the selection for scoring erosions,
KL scores in the DIPJs, PIPJs, first IPJs and first CMCJs
were summed to form an overall score (KLsum) for every
participant. The population was divided in subgroups by
the summation scores (range 072). All radiographs in
subgroups with KLsum 53 were scored. Random sam-
ples of at least 10% of subgroups with KLsum <3 were
screened for erosions.
Diagnosis of systemic inflammatory arthritis
Three sources of information were used to identify
potential cases of diagnosed systemic inflammatory
arthritis—specifically RA, seronegative RA, PsA and
scleroderma: retrospective local rheumatology hospital
medical records, retrospective general practitioner med-
ical records and the consultant radiologist’s clinical re-
ports on participant’s study radiographs. All searches
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were conducted by a researcher abstracting information
using a standard form and blinded to the study clinical as-
sessments and, in the cases of the medical records re-
views, the study radiographs. The abstracted information
on potential cases was reviewed by members of the re-
search team, including a consultant rheumatologist, to de-
termine which diagnosis was made. These persons were
used in the analyses of the comparison of clinical burden
between erosive OA and inflammatory arthritis and were
therefore excluded in the group used for erosive OA ana-
lyses only.
Clinical outcomes
General characteristics of age and gender were recorded
in postal surveys and height and weight were measured at
the research clinics held at a local rheumatology outpa-
tient department.
Hand pain and stiffness
The pain and stiffness subscales of the Australian/
Canadian Hand Osteoarthritis Index (AUSCAN; range
020 and 04, respectively) were completed by all partici-
pants [17]. Self-reported pain was also assessed with the
pain subscale of the Arthritis Impact Measurement Scales
health status questionnaire (AIMS-2; range 010) [18].
Higher scores indicate more pain or stiffness. The pres-
ence of pain in the finger IPJs and the thumb was deter-
mined from hand drawings; participants shaded areas
where they had experienced pain lasting 51 day during
the past month.
Hand function and performance
Self-reported hand function was assessed with the func-
tion subscales of the AUSCAN (range 036) and AIMS-2
hand and finger function subscale (range 010). Higher
scores represent a greater limitation in hand function.
The maximum gross and pinch grip strength was as-
sessed with the JAMAR dynomometer (Sammons
Preston, Chicago, IL) and B&L pinch gauge (B&L
Engineering, Tustin, CA), respectively. In addition, the
Grip Ability Test (GAT) was performed in the CAS-HA par-
ticipants [13]. The GAT consisted of three tasks (putting a
flexigrip stocking over the non-dominant hand, putting a
paperclip on an envelope, pouring water from a jug
into a cup) that participants had to perform within 23 min
[19, 20]. Scores are based on the time to complete the
three tasks; higher scores correspond to poorer hand
function. GAT scores <20 s are considered normal [19].
General health perceptions
General health perceptions were measured by the Short
Form 12 (SF-12), a widely used generic health status
questionnaire yielding summary component scores for
physical health (PCS; 0100) and mental health (MCS;
0100), where lower scores represent poorer perceived
health and a population average is 50 [21].
Aesthetics and impact of hand problems
The appearance of the hand was measured with the aes-
thetics subscale score of the Michigan Hand Outcomes
Questionnaire (MHQ; range 0100), which is composed of
four questions for both hands [22]. The impact of hand
symptoms was measured with the impact subscale of
the AIMS-2 (range 010). Higher scores represent more
satisfaction with aesthetics of the hand and a greater
impact.
Statistical analysis
The prevalence of erosive OA in the population with hand
symptoms and in the symptomatic radiographic hand OA
population was calculated by dividing the number of per-
sons with erosive OA by the sample size. Associated 95%
CIs were calculated based on a binomial distribution. The
true population prevalence of symptomatic erosive OA
was calculated using a combined approach of multiple
imputation and weighted logistic regression, calculated
for CAS-HA participants only [23]. Multiple imputation
was used to estimate erosive OA prevalence in partici-
pants unable to attend the clinical assessment; weighted
logistic regression was used to obtain prevalence rates
adjusted for participant’s likelihood to return the initial
survey questionnaire.
Linear regression analyses were used to investigate dif-
ferences in clinical characteristics between participants
with and without erosive OA and also those with erosive
OA in comparison with those with inflammatory arthritis.
The beta estimate is presented as the mean difference
(with 95% CI) adjusted for age and gender. Data of par-
ticipants with inflammatory arthritis were only used for the
comparison of the clinical burden outcomes between par-
ticipants with erosive OA and those with inflammatory
arthritis of the hand and for estimates of overall population
prevalence. The data were analysed using SPSS version
17 (SPSS Inc, Chicago, IL, USA) and STATA version 11.0
(Stata Corporation, College Station, TX, USA).
Results
Clinical characteristics and demographics
The cohorts yielded a combined sample of 1442 poten-
tially eligible participants. Participants with incomplete
radiographs (n= 47), without hand symptoms 51 day
during the last month (n= 275) and those with inflamma-
tory arthritis (n= 44) were excluded (Fig. 1), leaving a total
of 1076 eligible participants [60% women, mean age
64.8 years (S.D. 8.3)]. The 44 persons with inflammatory
arthritis were used in the analysis of clinical burden be-
tween erosive OA and inflammatory arthritis. Symptomatic
radiographic hand OA was present in 74% of participants
(Table 1).
Occurrence of erosive OA
Among the 80 persons with 51 erosive or remodelled
joint in their DIPJ, PIPJ or first IPJ, a total of 216 erosive
or remodelled joints were found (median 2, range 111),
most commonly in the second DIPJs in both hands (34
joints in DIP2 left, 39 joints in DIP2 right). The second
PIPJs (one joint in PIP2 left and right) were least com-
monly involved. Of the 216 joints, 34 joints (16%) were
2262 www.rheumatology.oxfordjournals.org
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in the E phase; the remainder was classed as R phase.
Twenty-three persons presented one or more E phase in
their hands and 57 persons presented only R phases. Of
the 23 persons, 76 erosive or remodelled joints were pre-
sent, whereas 140 erosive or remodelled joints were pre-
sent in the 57 persons with only R phase.
The true population prevalence estimate of erosive OA
in the general population of adults age 550 years was
2.4% (95% CI 1.8, 3.0). This represented 7.4% (95% CI
5.9, 9.2) of the subpopulation with hand symptoms in this
age range and 10.0% (95% CI 7.9, 12.1) of those with
symptomatic radiographic hand OA. The prevalence of
erosive OA in IPJs in the subpopulation with hand pain
in the IPJs was 15.2% (95% CI 12.1, 18.2) and in the
subgroup with symptomatic radiographic IPJ OA it was
23.3% (95% CI 18.8, 27.7). The prevalence of erosive
OA was examined by gender and it was found that esti-
mates for women were at least double those for men
(Table 2).
Clinical burden of erosive OA in relation to sympto-
matic radiographic hand OA
Persons with erosive OA reported significantly more pain,
stiffness and functional limitations than persons with
symptomatic non-erosive radiographic hand OA on both
AUSCAN and AIMS-2 questionnaires (Table 3). The power
grip and pulp pinch strength tended to be lower in per-
sons with erosive OA than those with symptomatic radio-
graphic hand OA, after adjustment for age and sex, but
not significantly different. In the performance of the GAT,
no significant differences in time taken to complete the
tasks were found between persons with erosive OA and
persons with symptomatic radiographic hand OA.
No statistically significant differences were seen in the
AIMS-2 impact subscale and PCS between persons with
erosive OA and those with symptomatic radiographic
hand OA. Persons with erosive OA scored significantly
better on the MCS but worse on the MHQ aesthetics sub-
scale than persons with symptomatic radiographic hand
OA (Table 3). The results mentioned above did not change
when the analyses were also adjusted for BMI.
Clinical burden in different stages of erosive OA
Within erosive OA, those with only R phases reported less
stiffness and better hand and finger function as assessed
by AIMS-2 than persons with at least one E phase on the
radiographs; also, self-reported hand function scores as-
sessed by AUSCAN were lower, however, this difference
was not statistically significant. There was no difference
between E and R phases in pain, AIMS-2 impact sub-
scale, MCS and MHQ aesthetic subscale. Furthermore,
those with only R phases had a better perception of
their perceived physical health than those with one or
more E phases on their radiographs [adjusted mean dif-
ference 5.8 (95% CI 0.2, 11.5); Table 4]. When adjusted for
BMI, the results did not change.
Clinical burden of erosive OA in relation to
inflammatory arthritis
A total of 44 cases of pre-existing systemic inflammatory
arthritis were identified (39 RA, 4 PsA, 1 scleroderma),
with a mean age of 66.2 years (S.D. 9.3 years) and a
mean BMI of 28.4 kg/m2 (S.D. 5.2 kg/m2). Sixty-one per
cent were women, which is significantly lower than in the
erosive OA patient group [mean difference 24.7% (95%
CI 41.3, 0.8)]. In 36 patients this diagnosis had been
made by a rheumatologist. The remaining eight relied on a
combination of general practitioner diagnosis and consult-
ant radiologist report on the study radiographs.
Compared with cases with diagnosed inflammatory
arthritis, persons with erosive OA had less hand pain, stiff-
ness and functional limitation on both the AUSCAN and
AIMS-2 subscales. Persons with erosive OA also had
better perceptions of both their physical and mental
health than persons with inflammatory arthritis. No differ-
ence was seen in the MHQ aesthetics subscale score be-
tween persons with erosive OA and those with
inflammatory arthritis (Table 5). The results did not
change when adjusted for BMI.
FIG. 1 Flow chart of selection of CAS-K and CAS-HA
participants for erosive OA analyses.
CAS-K & CAS-HA participants  
N=1442 
Exclusions – inflammatory arthritis 
N=44 
Exclusions – incomplete x-ray data 
N=47 
Exclusions – no hand symptoms lasting ≥ 1 
day during last month 
N=275 
Total included for analyses 
N=1076 
TABLE 1 Baseline characteristics of 1076 persons in the
population with hand symptoms lasting 51 day during
the last month
Female, n (%) 650 (60)
Age, mean (S.D.), years 64.8 (8.3)
BMI, mean (S.D.), kg/m2 29.1 (5.1)
Pain in at least one IPJ, n (%) 527 (49)
Pain in left or right thumb, n (%) 605 (56)
Symptomatic radiographic hand OAa, n (%) 798 (74)
Erosive personsb with IPJ erosions, n (%) 80 (7.4)
aPresence of KellgrenLawrence score 52 in at least one
DIPJ, PIPJ or first IPJ. bHaving at least one eroded (E phase)
or remodelled joint (R phase), according to the
VerbruggenVeys scoring method.
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TABLE 3 Demographic characteristics and clinical outcomes in the symptomatic radiographic hand OA subpopulation
(n= 798)
Outcome
Persons with symptomatic
RHOA (n= 718), mean (S.D.)
Persons with
EOA (n= 80), mean (S.D.)
Adjusted mean
differencea (95% CI)
Female, n (%) 442 (62) 67 (84) 22.2 (13.4, 31.0)
Age, years 66.1 (8.1) 69.2 (7.8) 3.1 (1.3, 5.0)
BMI, kg/m2 29.3 (5.1) 28.7 (5.1) 0.6 (1.7, 0.6)
AUSCAN pain 6.6 (4.2) 8.0 (4.2) 1.3 (0.3, 2.3)
AUSCAN stiffness 1.1 (0.9) 1.5 (1.0) 0.3 (0.1, 0.6)
AUSCAN function 10.4 (8.1) 13.8 (8.0) 2.3 (0.4, 4.2)
AIMS-2 pain subscale 3.8 (2.3) 4.7 (2.6) 0.8 (0.3, 1.4)
AIMS-2 hand/finger function 2.2 (2.1) 3.1 (2.4) 0.8 (0.2, 1.3)
AIMS-2 impact subscale 2.2 (2.1) 2.6 (2.2) 0.5 (0.05, 1.0)
Power grip, lbs 50.7 (25.6) 37.4 (18.9) 3.0 (7.1, 1.1)
Pulp pinch, lbs 10.3 (4.1) 8.4 (2.7) 0.3 (1.0, 0.4)
GAT 31.8 (12.9) 32.3 (9.8) 0.7 (4.7, 3.4)
SF-12 PCS 37.6 (11.8) 37.0 (11.3) 0.5 (2.4, 3.4)
SF-12 MCS 50.4 (10.8) 53.0 (9.3) 2.9 (0.2, 5.5)
MHQ aesthetics subscale 72.2 (20.5) 52.2 (23.7) 17.6 (22.8, 12.5)
Values are means (S.D.) unless stated otherwise, shown with the mean differences in outcomes between persons with and
without erosive OA. EOA is erosive hand OA in one or more IPJs (including DIPJ, PIPJ or first IPJ). aAdjusted for age and sex
(exception: crude mean differences for age and sex), 1 lb = 0.453 kg.
TABLE 4 Demographic characteristics and outcome measures of general health and disease-specific questionnaires
and performance tests in erosive persons (n= 80)
Outcome
Erosive, 51 E phase
(n= 23; 76 affected joints)
Erosive, R phase only
(n= 57; 140 affected joints)
Adjusted mean
differencea (95% CI)
AUSCAN pain 8.7 (4.6) 7.7 (4.0) 1.0 (3.0, 1.0)
AUSCAN stiffness 2.0 (0.9) 1.3 (1.0) 0.7 (1.2, 0.2)
AUSCAN function 15.5 (7.9) 13.1 (8.1) 2.4 (6.4, 1.5)
AIMS-2 pain subscale 5.3 (2.8) 4.4 (2.5) 0.8 (2.1, 0.5)
AIMS-2 hand/finger function 3.9 (2.7) 2.8 (2.2) 1.1 (2.2, 0.1)
AIMS-2 impact subscale 2.5 (2.3) 2.6 (2.2) 0.1 (1.0, 1.3)
SF-12 PCS 33.2 (11.1) 38.7 (11.1) 5.8 (0.2, 11.5)
SF-12 MCS 53.1 (9.5) 52.9 (9.3) 0.3 (5.1, 4.6)
MHQ aesthetics subscale 48.1 (23.7) 54.3 (23.7) 5.4 (6.6, 17.3)
Values are mean (S.D.) unless stated otherwise, stratified for the presence of erosive (E) or remodelled (R) phase with mean
differences of outcome between E phase and R phase persons. E phase: eroded joint according to the VerbruggenVeys
scoring method; R phase: remodelled joint according to the VerbruggenVeys scoring method. aAdjusted for age and sex;
PCS: physical component summary score; MCS: mental component summary score.
TABLE 2 Prevalence of erosive OA in the total population age 550 years in those with hand symptoms and symp-
tomatic radiographic hand OA, stratified for sex
Prevalence of EOA All Males Females
Total population age 550 years 2.4 (1.8, 3.0) 0.9 (0.3, 1.4) 3.7 (2.7, 4.7)
Subpopulation with hand pain 7.4 (5.9, 9.2) 3.1 (1.6, 5.2) 10.3 (8.0, 12.6)
Subpopulation with hand pain in IPJs as well (n= 527) 15.2 (12.1, 18.2) 7.3 (4.0, 12.2) 19.2 (15.1, 23.3)
Subpopulation with symptomatic RHOA 10.0 (7.9, 12.1) 4.5 (2.4, 7.6) 13.2 (10.2, 16.1)
Subpopulation with symptomatic RHOA in IPJs as well (n= 344) 23.3 (18.8, 27.7) 13.8 (7.6, 22.5) 26.8 (21.3, 32.3)
Numbers are percentages (range 0100%) with 95% CI in parentheses. Subpopulation with hand pain: having pain of the
hands 51 day during the last month; subpopulation with symptomatic radiographic hand OA: meeting the criteria for hand
symptoms and at least one joint in the DIPJs, PIPJs or first IPJs or the first CMCJ with a KellgrenLawrence score 52; IPJs:
including DIP, PIP or first IPJ. EOA: erosive OA; RHOA: radiographic hand OA.
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Discussion
This study makes several contributions to current know-
ledge on the occurrence and impact of erosive OA. First,
we have confirmed with a high degree of consistency,
previous estimates of the prevalence of erosive OA in
the general population. Second, we showed that in a
population-based study, symptomatic subjects with ero-
sive OA report more pain, functional disability and aes-
thetic damage as assessed with hand OAspecific
questionnaires than symptomatic subjects with non-ero-
sive radiographic signs. In this population-based study,
erosive OA does not appear to impact as strongly on
pain and function as prevalent inflammatory arthritis iden-
tified from the same population.
The additional value of the present study concerns the
detailed assessments of the hand (e.g. clinical examin-
ation, AUSCAN, AIMS-2 and SF-12) in contrast to the
Rotterdam and Framingham studies. The use of hand
OAspecific questionnaires in this study makes it possible
to quantify pain, functional limitation and health status in
erosive OA in a general population sample with hand
symptoms in more detail than previous studies have
allowed. In both the Rotterdam and Framingham studies,
a question about having hand pain or symptoms on most
days [8] or during the last month was asked [7], while the
Rotterdam Study, in addition, used the hand-specific
questions of the HAQ [24, 25] to describe the increased
disability in persons with erosive OA compared with the
general population [7]. However, the HAQ includes more
domains of functionality and these hand-specific ques-
tions were not validated in patients with hand OA [24,
25]. In the present study, the quantification of pain and
function could be made since both AUSCAN and AIMS-
2 were used, showing the same direction of the outcomes.
Another advantage of the present study is the additional
information obtained from the clinical examination and
the SF-12, which extends the knowledge regarding the
impact of erosive OA in people with symptomatic hand
OA.
The prevalence estimates in the present study are very
similar to those found in the Rotterdam Study. In the
Rotterdam Study, 2.8% of adults age 555 years in the
general population were estimated to have symptomatic
erosive OA (equivalent to 6.9% in those with hand symp-
toms and 10.2% in the subgroup with symptomatic radio-
graphic hand OA [7]). In the present study in adults age
550 years the estimates are 2.4%, 7.4% and 10.0%, re-
spectively. Recently Haugen et al. [8] reported apparently
higher prevalence estimates of erosive OA (9.9% for
women and 3.3% for men ages 4084 years) using data
from the Framingham Study. These estimates were based
on erosions defined by the Osteoarthritis Research
Society International (OARSI) atlas, while the Rotterdam
and Keele studies used the VerbruggenVeys scoring
method. More importantly, the Framingham estimates
were of erosive OA irrespective of symptoms.
Persons with erosive OA experience not only more pain,
but also more functional limitation and impact than those
with symptomatic radiographic hand OA, measured with
AUSCAN and AIMS-2 questionnaires. Scores of the
AUSCAN subscales in the present study were slightly
lower than those reported for persons with erosive OA in
secondary care [9]. Regardless of the study population, all
these studies confirm that persons with erosive OA have a
higher clinical burden than persons with symptomatic
radiographic hand OA. Persons with erosive OA did not
report poorer overall perceived physical health than per-
sons with hand OA, as reflected by the PCS. This finding is
in line with Bijsterbosch et al. [9], who reported no differ-
ence in health-related quality of life in persons with erosive
OA compared with persons with non-erosive OA.
The clinical burden of erosive OA is lower than prevalent
inflammatory arthritis in this population-based study.
Individuals with inflammatory arthritis experienced a
higher clinical burden than persons with erosive OA in
TABLE 5 Clinical outcomes for participants with erosive OA and those with inflammatory arthritis (n= 80 and n= 44)
Outcome
Persons with
EOA (n= 80), mean (S.D.)
Persons with inflammatory
arthritis (n= 44)a, mean (S.D.)
Mean differenceb
(95% CI)
Female, n (%) 67 (84) 26 (61) 24.7 (41.3, 0.8)
Age, years 69.2 (7.8) 66.2 (9.3) 3.0 (6.1, 1.6)
BMI, kg/m2 28.7 (5.1) 28.4 (5.2) 0.3 (2.3, 1.6)
AUSCAN pain 8.0 (4.2) 10.2 (4.1) 1.7 (0.05, 3.4)
AUSCAN stiffness 1.5 (1.0) 2.0 (0.8) 0.4 (0.02, 0.8)
AUSCAN function 13.8 (8.0) 20.3 (9.4) 6.3 (2.8, 9.9)
AIMS-2 pain subscale 4.7 (2.6) 6.1 (1.9) 1.2 (0.2, 2.2)
AIMS-2 hand/finger function 3.1 (2.4) 4.8 (2.9) 1.6 (0.5, 2.6)
AIMS-2 impact subscale 2.6 (2.2) 4.5 (2.9) 1.7 (0.8, 2.8)
SF-12 PCS 37.0 (11.3) 28.4 (9.5) 8.4 (12.9, 3.9)
SF-12 MCS 53.0 (9.3) 46.0 (11.3) 7.3 (11.5, 3.0)
MHQ aesthetics subscale 52.2 (23.7) 52.7 (27.5) 1.3 (11.6, 9.0)
Values are mean (S.D.) unless stated otherwise. EOA: erosive hand OA in one or more IPJs (including DIPJ, PIPJ or first IPJ).
aOne person of the inflammatory arthritis category was missing. bAdjusted for age and sex (crude mean differences for age
and sex).
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terms of pain, functional limitation and physical health
status. Recently Wittoek et al. [26] showed that patients
with erosive OA visiting a rheumatology clinic have more
funtional impairment and pain compared with patients
with controlled inflammatory arthritis. An explanation for
this contrary finding could be selection bias due to the
different setting of the investigation (general population
vs secondary care). Furthermore, the patients with inflam-
matory arthritis in the present study could have a higher
disease activity (however, this was not measured since
this was not the aim of the present study) than the patients
in the Belgian study. During the development of the Score
for the Assessment and Quantification of Chronic
Rheumatoid Affections of the Hands (SACRAH) question-
naire, which is a score for assessment and quantification
of chronic rheumatic affections of the hand, the scores
concerning function, pain and stiffness were not signifi-
cantly different between 69 OA and 103 RA patients
[11]. The finding of a lower perceived physical health
status in persons with inflammatory arthritis is in line
with a population-based study in Spain reporting mean
PCS scores from the SF-12 in persons with RA of 29.1
compared with 35.5 in persons with hand OA, after ad-
justment for age and sex [27]. The study of Slatkwosky
et al. [12] showed that patients with RA and hand OA
score worse on the SF-36 compared with the gen-
eral population, but RA patients score worse than OA pa-
tients (SF-36 score of 59.1 for hand OA patients, 48.4 for
RA patients and 81.6 for controls, respectively). However,
in all three above mentioned studies, direct comparison
with erosive OA was not investigated. The novelty of the
present study is that health-related quality of life, pain and
function scales of the AUSCAN and AIMS-2 in persons
with erosive OA were directly compared with persons
with inflammatory arthritis from the same source
population.
Several limitations in the present study deserve men-
tion. Although both cohorts (CAS-HA and CAS-K) gath-
ered comparable data, they were assembled in subtly
different ways: one based on knee symptoms, the other
on the basis of hand symptoms in the past 12 months.
Biased estimates from the knee cohort would be a con-
cern, although the difference in the frequency of erosive
OA between the two cohorts was not large (8.1% in CAS-
HA vs 6.8% in CAS-K), which justifies their combination.
The identification of cases of inflammatory arthritis was
based predominantly on a pre-existing recorded diag-
nosis by a rheumatologist. In the absence of a thorough
diagnostic screen for all inflammatory arthritis in the
research clinics (which was beyond the scope of the
present study), there could be the potential for some
cases of inflammatory arthritis to have been missed due
to incomplete records or early arthritis not yet diagnosed.
Also, no specific information about swollen tender joints
(such as disease activity scores like the DAS28) was
available.
Furthermore, the number of persons with erosive OA,
differentiation between E and R phases and persons with
inflammatory arthritis were small and results may not be
significant due to these small numbers. However, no ear-
lier studies investigated these groups in detail with spe-
cific outcomes. These results need to be confirmed in
future studies. In conclusion, erosive OA in the general
population is an infrequent hand OA subset that occurs
mostly in the DIPJs, with a predominance in females, and
has consistent and substantial impact on pain and self-
reported function, although appearing not as great as in
persons with prevalent inflammatory arthritis.
Rheumatology key messages
. Erosive OA as a subset occurs infrequently in the
general population, mostly in females and in the
DIPJs.
. The clinical impact of erosive OA is less severe than
inflammatory arthritis in a general population.
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